Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,742 across all filing types
Latest filing 2026-03-09 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
《公司章程》修订对照表
Governance Information Classification · 95% confidence The document text is a detailed comparison table showing amendments to the company's Articles of Association (公司章程). It includes specific changes to governance provisions such as the scope of business, shareholder meeting resolutions, board responsibilities, and financial budget approvals. This type of document is focused on the company's internal governance rules and structural changes to its bylaws. There is no indication of financial statements, audit results, earnings data, or shareholder voting results. It is not a report publication announcement or a brief notice. The content aligns with a Governance Information report, which details the company's internal rules, board structure, and governance practices.
2026-03-09 Chinese
关于公司未弥补亏损达到实收股本总额三分之一的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement by the company regarding its accumulated losses reaching one-third of its paid-in capital, which is a regulatory disclosure under Chinese company law. It includes details about the financial condition, causes of losses, and measures taken, but it is not a full financial report or audit report itself. The document references audited financial statements but does not contain the full audit report or detailed financial statements. It also mentions board resolutions and shareholder meeting submissions. The document length is short (1503 characters) and serves as a formal public announcement of a significant financial condition and related corporate actions. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like Annual Report, Audit Report, or Interim Report.
2026-03-09 Chinese
2025年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2025 年度董事会工作报告' which translates to '2025 Annual Board of Directors Work Report'. It details the activities, meetings, and resolutions of the board throughout the year 2025, including financial performance summaries, board meeting counts, agenda items, and future outlook. The content focuses on the board's work and governance activities rather than full financial statements or audit opinions. It is a comprehensive report on board and management activities for the year, consistent with a Board/Management Information filing. The document length is 7644 characters, which is substantive and contains detailed information rather than a brief announcement or certification. Therefore, the appropriate classification is Board/Management Information (MANG).
2026-03-09 Chinese
公司2025年度会计师事务所履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the auditing firm for the fiscal year 2025. It details the auditor's background, audit procedures, quality control, and the audit opinion issued. It does not contain the full annual financial statements or comprehensive company activity but focuses on the auditor's role and assessment. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and related information excluding full annual reports. The document length is 2609 characters, which is relatively short but contains substantive audit-related content, not just an announcement or certification. Therefore, it is classified as AR with high confidence. FY 2025
2026-03-09 Chinese
关联方占用资金情况专项报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项报告" (special report) concerning related party non-operating fund occupation and other related party fund transactions for the fiscal year 2025. It references an audit report issued on March 6, 2026, and includes detailed tables summarizing related party fund usage and balances. The document is a standalone special report focusing on related party fund occupation, prepared in accordance with regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange. It is not a full annual report (10-K), nor an earnings release or management discussion. It is also not a simple announcement or certification but a detailed audit-related report on a specific financial issue. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific financial matters. The document length is 2401 characters, which is short but contains substantive financial data and audit conclusions, not merely an announcement. Therefore, the best classification is AR with high confidence. FY 2025
2026-03-09 Chinese
2025年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "审计报告及财务报表" (Audit Report and Financial Statements) for the fiscal year 2025, covering the period from January 1, 2025 to December 31, 2025. It includes an audit opinion, detailed audit procedures, key audit matters, and comprehensive financial statements such as consolidated and parent company balance sheets, profit and loss statements, and cash flow statements. The presence of an independent auditor's opinion and detailed financial data confirms this is a full audit report with financial statements, not just an announcement or certification. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief notice. Therefore, the document fits the category of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or other categories. FY 2025
2026-03-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.